Streetbeat News

Products Services

RNA

Avidity Biosciences Inc announced new data for its lead clinical program, AOC 1001, showing improvement in multiple functional endpoints and favorable long-term safety for myotonic dystrophy type 1 (DM1). The data from the Phase 1/2 MARINA trial and MARINA open-label extension study will be highlighted at the 28th Annual Congress of the World Muscle Society. The company plans to share AOC 1001 data from the MARINA-OLE study in the first half of 2024 and is finalizing the Phase 3 study design and global regulatory path for AOC 1001. RNA shares are down 1.13% at $6.12 on the last check Monday.

Portfolio Pulse from Vandana Singh

October 09, 2023 | 4:37 pm

NVAX

Novavax has announced that its updated Covid-19 vaccine has been shipped to distributors and expects the shots to be available this week.

Portfolio Pulse from Benzinga Newsdesk

October 09, 2023 | 4:02 pm

MAT

Mattel, Inc. (NASDAQ:MAT) and Off-White™ have announced a partnership to create a capsule collection of four original Monster High dolls dressed in Off-White™ runway ensembles. The collaboration is a fusion of Off-White™'s disruption of fashion norms and Monster High's celebration of individuality. The limited-edition collection includes four dolls with unique personalities and a musical punk twist. The dolls will be first introduced in Off-White™ flagship locations in Miami, New York City, Las Vegas, Paris and Milan on October 11th, and will be available on MattelCreations.com and Off-White.com from October 13th.

Portfolio Pulse from Benzinga Newsdesk

October 09, 2023 | 4:01 pm

WMT

Coca-Cola Co's shares are trading lower due to several factors. The company is facing potential lower demand due to increased health awareness and preference for healthier alternatives. Additionally, the recent surge in Treasury yields is negatively impacting dividend-oriented stocks like Coca-Cola. Walmart's CEO's comments about weight loss drugs impacting food sales also contribute to the sector's weakness.

Portfolio Pulse from Henry Khederian

October 09, 2023 | 3:49 pm

INTC

NOK

ORAN

VOD

Vodafone Group Plc is partnering with Intel Corp to develop a specialized chipset architecture for Open RAN networks. The telecom company has also conducted its first 4G calls using Open RAN on network sites it shares with Orange in Romania. A partnership with Nokia Corp is also in progress to trial the technology in Italy. However, the adoption of Open RAN technology has been slow, with companies like Ericsson, Nokia, and Huawei Technologies Co. still dominating the market with their proprietary solutions.

Portfolio Pulse from Anusuya Lahiri

October 09, 2023 | 3:49 pm

GOOG

GOOGL

Google Cloud, a division of Alphabet Inc, has introduced AI-powered search tools to help healthcare professionals retrieve clinical information from various medical records. The technology consolidates data from different sources into a single location, addressing the issue of fragmented data storage systems in healthcare. The tool also assists in billing and identifying candidates for clinical trials. Early access is open to healthcare and life sciences organizations, with ongoing tests involving Mayo Clinic, Hackensack Meridian Health, and Highmark Health.

Portfolio Pulse from Anusuya Lahiri

October 09, 2023 | 3:44 pm

AAPL

SSNLF

The Biden administration has granted Samsung Electronics Co (OTC:SSNLF) and SK Hynix Inc permission to acquire equipment essential for maintaining and expanding their chipmaking operations in China. This move comes as a waiver to the broader restrictions that prohibited the shipment of advanced chipmaking gear to China. The easing of restrictions ensures that memory chips produced in China can be integrated into various products, including those assembled for U.S. companies like Apple Inc (NASDAQ: AAPL).

Portfolio Pulse from Anusuya Lahiri

October 09, 2023 | 3:40 pm

GSK

GSK plc has entered into an exclusive agreement with Chongqing Zhifei Biological Products to co-promote GSK's shingles vaccine, Shingrix, in China. The deal, worth £2.5 billion over three years, will significantly extend the availability of Shingrix in China. Zhifei will have exclusive rights to import and distribute Shingrix in China from January 2024. The partnership is expected to support GSK's goal of doubling global Shingrix sales to more than £4 billion by 2026.

Portfolio Pulse from Vandana Singh

October 09, 2023 | 3:26 pm

CTLT

LLY

NVO

PFE

TMO

The weight-loss drug market is experiencing a boom, leading to a rapid growth in the fill-finish market. Companies like Novo Nordisk, Eli Lilly, and Pfizer are driving this growth with their weight-loss drugs. Contract drug manufacturers like WuXi Biologics and Catalent Inc are investing heavily in expanding their facilities to meet the rising demand. The fill-finish market is expected to double to $12.5 billion between 2019 and 2027.

Portfolio Pulse from Vandana Singh

October 09, 2023 | 3:21 pm

ALSN

Allison Transmission Holdings Inc (ALSN) is partnering with B-Metro, the public transit system in Brownsville, Texas, to provide the Allison eGen Flex electric hybrid propulsion system for 35-foot GILLIG buses. Brownsville recently received a $4.7 million grant from the Federal Transit Administration's 2023 Low or No Emission Program and named Allison's eGen Flex electric hybrid technology in its application for the grant. The eGen Flex system's electric-only mode has geofencing technology, which will enable the new buses to automatically switch into engine-off mode in pre-defined zero-emission zones.

Portfolio Pulse from Shivani Kumaresan

October 09, 2023 | 3:10 pm